共 50 条
- [31] Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions: The TARGET I TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B7 - B8Xu, BoGao, Run-LinLansky, AlexandraYang, YuejinMa ChangshengHan, YalingChen, Shao LiangLi, HuiZhang, RuiyanFu, GuoshengYuan, ZuyiHuo, YongLi, WeiZhao, YelinLeon, Martin
- [32] Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trialEUROINTERVENTION, 2012, 8 (07) : 796 - 802Xu, BoDou, KefeiYang, YuejinLv, ShuzhengWang, LefengWang, HaichangLi, ZhanquanWang, LeiChen, YundaiHuo, YongLi, WeiKirtane, Ajay J.Gao, Runlin
- [33] Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries:: double-blind, randomised controlled trial (E-SIRIUS)LANCET, 2003, 362 (9390): : 1093 - 1099Schofer, JSchlüter, MGershlick, AHWijns, WGarcia, ESchampaert, EBreithardt, G
- [34] Everolimus-eluting stent for the treatment of de novo coronary lesions -: Angiographic follow-up of the FUTURE trialCIRCULATION, 2003, 108 (17) : 703 - 703Costa, RALansky, AMehran, RTsuchiya, YCristea, ENegoita, MNikolsky, EFahy, MPop, RGilutz, YLeon, MGrube, E
- [35] SIROLIMUS ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS ELUTING STENT WITH DURABLE POLYMER FOR THE TREATMENT OF PATIENTS WITH DE NOVO CORONARY ARTERY LESIONS (EVOLUTION): A RANDOMIZED NON-INFERIORITY TRIALJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E283 - E283Ge, JunboGe, LeiQian, JuyingFu, GuoshengLiu, HuiliangMa, GenshanMa, YitongFang, WeiyiLi, HuiZhou, YujieQin, YongwenLi, YigangCui, LianqunLu, ChengzhiLiu, BinTang, JifeiZhang, ZhengXiang, MeixiangGuang, XuefengZhang, DadongHe, Qing
- [36] Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions - An intravascular ultrasound analysisCIRCULATION, 2003, 108 (22) : 2747 - 2750Degertekin, MSerruys, PWTanabe, KLee, CHSousa, JEColombo, AMorice, MCLigthart, JMRde Feyter, PJ
- [37] Impact of sirolimus-eluting stents on outcome in diabetic patients - A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyCIRCULATION, 2004, 109 (19) : 2273 - 2278Moussa, ILeon, MBBaim, DSO'Neill, WWPopma, JJBuchbinder, MMidwall, JSimonton, CAKeim, EWang, PKuntz, REMoses, JW
- [38] Safe and effective profile of the VSTENT bioresorbable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions: a prospective, cohort, multicenter studyCARDIOVASCULAR DIAGNOSIS AND THERAPY, 2023, 13 (03) : 474 - 486Tran, HoaHoang, VuNguyen, Khang DuongHuynh, Thuong VanPham, Nhut CongNguyen, Khoa MinhPhan, Thanh VanNguyen, Trung VinhTran, Huan VanHuynh, Cang TrungLam, Giang HuuPham, Bang QuocHo, Dung ThuongNguyen, Tan VanPhan, Truc VanNguyen, ThachTruong, Binh Quang
- [40] 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions)JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1190 - 1198Garg, ScotSerruys, PatrickOnuma, YoshinobuDorange, CecileVeldhof, SusanMiquel-Hebert, KarineSudhir, KrishnankuttyBoland, JeanHuber, KurtGarcia, Eulogiote Riele, Jan A. M.